PFM Health Sciences’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-48,444
| Closed | -$6.21M | – | 76 |
|
|
2025
Q2 | $6.21M | Buy |
48,444
+1,991
| +4% | +$207K | 0.53% | 39 |
|
|
2025
Q1 | $4.11M | Buy |
46,453
+3,613
| +8% | +$352K | 0.3% | 45 |
|
|
2024
Q4 | $3.74M | Buy |
+42,840
| New | +$3.92M | 0.23% | 60 |
|
|
2023
Q1 | – | Sell |
-130,366
| Closed | -$5.71M | – | 86 |
|
|
2022
Q4 | $5.71M | Hold |
130,366
| – | – | 0.2% | 73 |
|
|
2022
Q3 | $8.59M | Buy |
+130,366
| New | +$8.37M | 0.31% | 66 |
|
|
2019
Q2 | – | Sell |
-964,075
| Closed | -$77.2M | – | 90 |
|
|
2019
Q1 | $77.2M | Sell |
964,075
-506,361
| -34% | -$37.4M | 1.71% | 23 |
|
|
2018
Q4 | $79.3M | Buy |
1,470,436
+30,398
| +2% | +$1.85M | 2.11% | 15 |
|
|
2018
Q3 | $112M | Buy |
1,440,038
+595,957
| +71% | +$41.4M | 1.65% | 14 |
|
|
2018
Q2 | $53.6M | Sell |
844,081
-73,909
| -8% | -$5.88M | 0.84% | 43 |
|
|
2018
Q1 | $84.2M | Buy |
917,990
+51,250
| +6% | +$4.42M | 1.71% | 18 |
|
|
2017
Q4 | $65.4M | Sell |
866,740
-762,346
| -47% | -$53.6M | 1.55% | 25 |
|
|
2017
Q3 | $113M | Buy |
1,629,086
+342,636
| +27% | +$18.3M | 2.23% | 8 |
|
|
2017
Q2 | $65.2M | Buy |
1,286,450
+234,438
| +22% | +$9.95M | 1.76% | 21 |
|
|
2017
Q1 | $42.1M | Buy |
1,052,012
+252,061
| +32% | +$9.03M | 1.05% | 41 |
|
|
2016
Q4 | $22.4M | Buy |
799,951
+246,866
| +45% | +$7.44M | 0.63% | 53 |
|
|
2016
Q3 | $16.4M | Sell |
553,085
-1,093,431
| -66% | -$27.2M | 0.48% | 61 |
|
|
2016
Q2 | $33.3M | Buy |
1,646,516
+226,005
| +16% | +$4.11M | 1.01% | 45 |
|
|
2016
Q1 | $25.6M | Buy |
1,420,511
+412,279
| +41% | +$7.15M | 0.79% | 43 |
|
|
2015
Q4 | $26.6M | Sell |
1,008,232
-19,321
| -2% | -$435K | 0.81% | 42 |
|
|
2015
Q3 | $21M | Buy |
1,027,553
+165,388
| +19% | +$4.57M | 0.59% | 48 |
|
|
2015
Q2 | $20.9M | Buy |
+862,165
| New | +$24.6M | 0.53% | 55 |
|
Other funds holding BPMC
IA
HNB
PFM Health Sciences's BPMC Position: Q3 2025 in Review
PFM Health Sciences sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 48,444 shares — an estimated $6.21M sold.
PFM Health Sciences first reported a position in BPMC in Q2 2015 and held it in 21 quarters. The position peaked at $113M in Q3 2017. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- PFM Health Sciences reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- PFM Health Sciences sold 48,444 Blueprint Medicines shares in Q3 2025, an estimated $6.21M.
- PFM Health Sciences first reported a position in Blueprint Medicines in Q2 2015 and held it in 21 quarters.
- PFM Health Sciences's Blueprint Medicines position peaked at $113M in Q3 2017.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on PFM Health Sciences's 13F filing for Q3 2025, filed 14 Nov 2025.